Commentary on the viewpoint of Nyman et al

Radiology

Volumn 223, Issue 2, 2002, Pages 328-329

  Spinosa, David J ^a   Kaufmann, John A ^a   Hartwell, Gary D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angiography, contrast media; Contrast media, complications; Contrast media, effects; Contrast media, toxicity; Gadolinium; Iodine and iodine compounds; Uremia

Indexed keywords

GADOLINIUM CHELATE; IODINATED CONTRAST MEDIUM;

ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; HUMAN; NEPHROTOXICITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0036237789     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2232011487     Document Type: Short Survey

References (8)

1. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?
2. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography
3. Feasibility of gadodiamide compared with dilute iodinated contrast material for imaging of the abdominal aorta and renal arteries
4. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both
5. Contrast-medium-induced acute renal failure
6. The effect of acute renal failure on mortality: A cohort analysis
7. Gadolinium chelates in angiography and interventional radiology: A useful alternative to iodinated contrast media for angiography
8. Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency